Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-19-003571

Options or other derivatives

  • Chief Financial Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Downs Christopher · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-11-13 Grant or award : show line 1 in the form Option to purchase common stock (right to buy) +300,000 300,000 D
Loading xslF345X03/ownership.xml…